SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
about
Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival.Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma.GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesisExpression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients.Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy.Retinoids regulate stem cell differentiationThe SOX family of genes in cancer development: biological relevance and opportunities for therapy.Retinoic acid plays an evolutionarily conserved and biphasic role in pancreas development.Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma.MiniSOX9, a dominant-negative variant in colon cancer cells.Sox9b is a mediator of retinoic acid signaling restricting endocrine progenitor differentiation.miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer.Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer.The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.
P2860
Q35856469-504D115B-D3FD-486B-AEB3-8781D55870C5Q35870326-ADBEE836-FFC2-4CD2-9BC6-3B11BB69D915Q36197098-585B20EF-1B15-46E8-BA47-2E9FD471DA27Q36299435-8BE19258-2AFB-42EB-996A-92BB766A827AQ36450462-F2863AD9-4598-41A4-9197-4B87ED534D5CQ36647355-507356AD-5BB3-4D09-8D64-DA51CCB8EAA1Q37111204-AE1EC2B8-449F-4689-B52F-FAF17DAF382CQ37428314-055BE982-0842-44E2-A972-98D90F0884E1Q37788067-AC9338A8-FAC6-4A44-9E43-44189F1140FEQ38029732-8EA615DB-C51C-4967-A350-B190B9F09876Q38965604-0E683D53-FD0C-4CAB-A79B-A93B9F525C5EQ39001596-F7945273-607C-477F-8319-F4DEB2A50097Q39270773-BDCBF6C8-DD1C-4221-A6CA-8FD3E6A32FD9Q39597052-8F763692-A1FE-4C01-A2A8-BCA95E1855CEQ41639895-3370F711-EE57-4EDC-A85A-BF3671206EFDQ41859748-6C350142-1CAC-497F-A4FB-AF9449EBFCF0Q47114999-6AAF9383-866E-4F79-9387-E90AA4ECC97DQ47136791-7CD754DD-F164-40C7-8EE0-C6296BE8CCDCQ55379875-6EB7DD5D-B875-4A4D-9C51-03F16CFA21A5
P2860
SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@en
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@nl
type
label
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@en
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@nl
prefLabel
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@en
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@nl
P2093
P1476
SOX9 mediates the retinoic aci ...... in human breast cancer cells.
@en
P2093
Anders Ström
Ben S Newman
Justin D Crofts
Laura C Bridgewater
Patrick Müller
P2860
P2888
P304
P356
10.1007/S10549-009-0381-6
P407
P577
2009-03-26T00:00:00Z